lumasiran sodium

Spain

Drugs containing this active substance

  • OXLUMO 94.5 MG/0.5 ML SOLUTION FOR INJECTION

    It is used to treat primary hyperoxaluria type 1 (PH1) in adults and children of any age. This disease causes the liver to produce an excess of oxalate, which can cause kidney stones and damage the kidneys, eyes, heart, skin, and bones.

    Form: solution for injection

    Active substance Dosage
    lumasiran sodium 100 mg

    ATC: A16A A16AX A16AX18

    Manufacturer: Alnylam Netherlands B.V.